07:00 , Apr 27, 2015 |  BC Week In Review  |  Clinical News

Amplidiag C regulatory update

Mobidiag received CE Mark approval for its Amplidiag C. difficile+027 test to detect Clostridium difficile infection and for differentiation of the hypervirulence-associated 027 ribotype from stool samples. The qPCR-based diagnostic is available in Europe. Mobidiag...